Literature DB >> 12860848

Enhanced external counterpulsation for refractory angina pectoris.

R M Sinvhal1, R M Gowda, I A Khan.   

Abstract

Enhanced external counterpulsation (EECP) is a non-invasive outpatient treatment used for angina pectoris. In patients with intractable angina refractory to aggressive surgical and medical treatment, several novel strategies are considered including EECP, transmural laser revascularisation, and spinal cord stimulation. EECP produces an acute haemodynamic effect that is presumed to be similar to that produced by the invasive intra-aortic balloon pump. By applying a series of compressive cuffs sequentially from the calves to the thigh muscles upon diastole and rapidly deflating the cuffs in early systole, an increase in diastolic and decrease in systolic pressure is created. Although data indicate improvement in angina in patients undergoing EECP, the role of EECP in the treatment of angina pectoris has not yet been well defined. At present, EECP use should be limited to patients with debilitating (functional class III and IV) refractory angina pectoris who are not candidates for revascularisation, are symptomatic despite being on maximal antianginal pharmacotherapy, and have no contraindications to EECP use.

Entities:  

Mesh:

Year:  2003        PMID: 12860848      PMCID: PMC1767754          DOI: 10.1136/heart.89.8.830

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  20 in total

1.  Comparison of hemodynamic effects of enhanced external counterpulsation and intra-aortic balloon pumping in patients with acute myocardial infarction.

Authors:  I Taguchi; K Ogawa; A Oida; S Abe; N Kaneko; H Sakio
Journal:  Am J Cardiol       Date:  2000-11-15       Impact factor: 2.778

2.  Acute hemodynamic effects and angina improvement with enhanced external counterpulsation.

Authors:  T Stys; W E Lawson; J C Hui; G Lang; J Liuzzo; P F Cohn
Journal:  Angiology       Date:  2001-10       Impact factor: 3.619

3.  Can angiographic findings predict which coronary patients will benefit from enhanced external counterpulsation?

Authors:  W E Lawson; J C Hui; Z S Zheng; L Burger; L Jiang; O Lillis; H S Soroff; P F Cohn
Journal:  Am J Cardiol       Date:  1996-05-15       Impact factor: 2.778

4.  Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease.

Authors:  H Urano; H Ikeda; T Ueno; T Matsumoto; T Murohara; T Imaizumi
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

5.  The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results.

Authors:  G Barsness; A M Feldman; D R Holmes; R Holubkov; S F Kelsey; E D Kennard
Journal:  Clin Cardiol       Date:  2001-06       Impact factor: 2.882

6.  Does higher diastolic augmentation predict clinical benefit from enhanced external counterpulsation?: Data from the International EECP Patient Registry (IEPR).

Authors:  A D Michaels; E D Kennard; S E Kelsey; R Holubkov; O Soran; S Spence; T M Chou
Journal:  Clin Cardiol       Date:  2001-06       Impact factor: 2.882

7.  Benefit and safety of enhanced external counterpulsation in treating coronary artery disease patients with a history of congestive heart failure.

Authors:  W E Lawson; E D Kennard; R Holubkov; S F Kelsey; J E Strobeck; O Soran; A M Feldman
Journal:  Cardiology       Date:  2001       Impact factor: 1.869

8.  Effects of enhanced external counterpulsation on Health-Related Quality of Life continue 12 months after treatment: a substudy of the Multicenter Study of Enhanced External Counterpulsation.

Authors:  Rohit R Arora; Tony M Chou; Diwakar Jain; Bruce Fleishman; Lawrence Crawford; Thomas McKiernan; Richard Nesto; Carol Estwing Ferrans; Susan Keller
Journal:  J Investig Med       Date:  2002-01       Impact factor: 2.895

9.  Treatment benefit in the enhanced external counterpulsation consortium.

Authors:  W E Lawson; J C Hui; G Lang
Journal:  Cardiology       Date:  2000       Impact factor: 1.869

10.  Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study.

Authors:  W E Lawson; J C Hui; P F Cohn
Journal:  Clin Cardiol       Date:  2000-04       Impact factor: 2.882

View more
  5 in total

Review 1.  New Advances in the Management of Refractory Angina Pectoris.

Authors:  Kevin Cheng; Ranil de Silva
Journal:  Eur Cardiol       Date:  2018-08

Review 2.  Contemporary Management of Refractory Angina.

Authors:  Rebekah Lantz; Odayme Quesada; Georgia Mattingly; Timothy D Henry
Journal:  Interv Cardiol Clin       Date:  2022-07

Review 3.  Treatment of refractory angina in patients not suitable for revascularization.

Authors:  Timothy D Henry; Daniel Satran; E Marc Jolicoeur
Journal:  Nat Rev Cardiol       Date:  2013-12-24       Impact factor: 32.419

4.  Reduced peripheral vascular reactivity in refractory angina pectoris: Effect of enhanced external counterpulsation.

Authors:  Susanne M Bondesson; Marie-Louise Edvinsson; Thomas Pettersson; Lars Edvinsson
Journal:  J Geriatr Cardiol       Date:  2011-12       Impact factor: 3.327

Review 5.  Enhanced external counterpulsation: A unique treatment for the "No-Option" refractory angina patient.

Authors:  Jose Caceres; Patricia Atal; Rohit Arora; Derek Yee
Journal:  J Clin Pharm Ther       Date:  2021-01-07       Impact factor: 2.512

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.